Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024Molecular Cancer TherapeuticsOpen Access

Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMatthew A. MurrayAuburn UniversityKNKatelyn J. NoronhaUniversity of New HavenYWYazhe WangNanchang University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Murray et al. (2024) studied this question.

synapsesocial.com/papers/68e6c04ab6db64358763fdc9https://doi.org/10.1158/1535-7163.mct-24-0012
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IDH1: Linking Metabolism and Epigenetics2018 · 68 citations
  2. 2Challenges to curing primary brain tumours2019 · 1,010 citations
  3. 3Tsc2 knockout counteracts ubiquitin-proteasome system insufficiency and delays photoreceptor loss in retinitis pigmentosa2022 · 18 citations
  4. 4The Smart Targeting of Nanoparticles2013 · 370 citations
  5. 5Mechanism-based design of agents that selectively target drug-resistant glioma2022 · 120 citations